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Abstract: Mycoplasma species cannot be identified by routine bacteriological culture methods 
and are resistant to common antimicrobial agents. Mycoplasma hominis usually colonizes the 
lower urogenital tract and causes pyelonephritis, pelvic inflammatory disease, chorioamnionitis, 
rupture of fetal membranes, preterm labor, postpartum fever, postabortal fever, and neonatal 
infection. This organism is highly prevalent in cervicovaginal cultures of sexually active women. 
M. hominis, M. genitalis, Ureaplasma urealyticum, and U. parvum may invade and infect 
placental and fetal tissues, leading to adverse pregnancy outcomes. M. hominis occasionally 
causes nongenitourinary infection of the blood, wounds, central nervous system, joints, or 
respiratory tract. We present a case of a 27-year-old woman who developed abdominal wound 
hematoma and abscess after cesarean section. The wound was drained, but her high fever 
persisted, in spite of antibiotic treatment using flomoxef sodium and imipenem⋅cilastatin sodium. 
Because the exudate exhibited M. hominis growth in an anaerobic environment, we administered 
the quinolone ciprofloxacin. This therapy resolved her fever, and her white blood cell count 
and C-reactive protein level diminished to the normal ranges. To our knowledge, there are four 
published articles regarding the isolation of M. hominis from postcesarean incisions. Based on 
the current study and the literature, infection by this pathogen may cause hematoma formation 
with or without abscess after cesarean section or in immunosuppressed postoperative patients. 
In such cases, physicians may need to suspect Mycoplasma infection and initiate appropriate 
antibacterial treatment as soon as possible in order to avoid persistent fever.
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Introduction
Mycoplasma hominis usually colonizes the lower urogenital tract and can cause 
pyelonephritis, pelvic inflammatory disease, chorioamnionitis, rupture of fetal 
membranes, preterm labor, postpartum fever, postabortal fever, and neonatal infection.1–9 
This organism is a marker for sexual activity, as demonstrated by its higher prevalence 
in cervicovaginal cultures of sexually active women than in those before sexual debut. 
M. hominis, M. genitalis, Ureaplasma urealyticum, and U. parvum may invade and 
infect placental and fetal tissues, leading to adverse pregnancy outcomes.1 In particular, 
M. hominis and U. urealyticum have been documented to cause genital tract infectious 
diseases for several decades. M. hominis occasionally causes nongenitourinary infection 
of the blood, wounds, central nervous system, joints, or respiratory tract.10,11 To our 
knowledge, there are four published articles regarding the isolation of this pathogen from 
postcesarean incisional infections.5,12–14 We present a case of M. hominis infection after 
cesarean section. This case report and the literature provide the features of postoperative 
infection with this organism, of which physicians should remain mindful.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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Case presentation
A 27-year-old woman, para 0, underwent emergency cesarean 
section because of labor arrest and cephalopelvic dispro-
portion at 39 weeks of gestation. A transverse skin incision 
was made at the lower abdomen, and the patient was deliv-
ered of an infant with meconium-stained amniotic fluid. Four 
1 g doses of flomoxef sodium prophylaxis were administered 
intravenously. The first dose was infused at the start of the 
operation, followed by the other doses 12, 24, and 36 hours 
later. On postoperative day 5, the patient developed a fever 
of 39.0°C and erythema with swelling and tenderness around 
the abdominal wound. Blood examination revealed a white 
blood cell count of 18,400/mm3 and a C-reactive protein 
(CRP) level of 15.4 mg/dL (Figure 1). A lower abdominal 
computed tomography (CT) scan revealed subcutaneous 
hematoma and rectus abdominis muscle abscess (Figure 2). 
These findings prompted us to open the central portion of 
her abdominal wound (approximately 2 cm width) under 
local anesthesia, for the purpose of drainage. A bloody 
purulent exudate was obtained from the incision, which 
was subjected to bacteriological culture. The Gram stain 
indicated numerous altered polymorphonuclear leukocytes 
without any pathogens (Figure 3). We irrigated the incision 
with 100 mL of saline daily and intravenously administered 
1 g flomoxef sodium twice daily. On day 8, an abdominal 
CT scan suggested that the subcutaneous hematoma and 
rectus abdominis muscle abscess had subsided (Figure 2), 
indicating that our drainage was effective. Nevertheless, her 
fever persisted, and the white blood cell count and CRP level 
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Figure 1 Body temperature (BT), white blood cell count (WBC), and C-reactive 
protein (CRP) level after cesarean section. One gram of flomoxef sodium (FMOX) 
twice daily, 500 mg of imipenem⋅cilastatin sodium (1:1; IPM/Cs) twice daily, and 
300  mg  of  ciprofloxacin  (CPFX)  twice  daily  were  administered  intravenously. 
Solid line: WBC; broken line: CRP. CPFX chemotherapy resolved the patient’s fever 
when WBC and CrP diminished to their normal ranges.
À
Postoperative day 5
Postoperative day 8
Figure 2 Computed tomography scans. rectus abdominis muscle abscess (arrow) 
and subcutaneous hematoma (arrowhead) were revealed on postoperative day 5 
and had subsided on day 8.
Figure 3 Gram stain of the abdominal incisional exudate. This indicates numerous 
altered polymorphonuclear leukocytes without any pathogens.
remained high. On day 7, we began an intravenous infusion of 
imipenem⋅cilastatin sodium (1:1; 500 mg) twice daily, instead 
of flomoxef sodium. On day 10, the abdominal incisional 
exudative fluid specimen obtained on day 5 revealed the 
growth of tiny colonies on a sheep blood agar culture plate 
under anaerobic conditions. The colonies were pinpoint sized, 
translucent, measuring 50–300 µm in diameter, and grew on 
blood agar in an anaerobic or 5% carbon dioxide atmosphere 
in 2–3 days but showed no growth in an aerobic environment 
in subculture. On Gram stain of the colonies, the cells were 
so small that their cellular morphology was invisible under a 
routine light microscope (Figure 4). The isolate was identified 
as M. hominis based on morphology of colonies, size of cells, 
and culture condition, being compatible with unsuccessful 
chemotherapy using a β-lactam agent. Therapy with a 
quinolone, ciprofloxacin (300 mg twice daily), was started 
intravenously, and imipenem⋅cilastatin sodium therapy was 
discontinued. This antibacterial treatment, during which 
breastfeeding was avoided, was continued until day 14 when International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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her fever was resolved. The white blood cell count and CRP 
level diminished to their normal ranges, and the patient was 
discharged home 21 days after the cesarean section.
Discussion
Mycoplasma species lack a cell wall. They appear as 
an amorphous mass on Gram staining and are therefore 
unidentifiable by this method.9,13 In addition, M.   hominis 
is a slow-growing bacterium, and its identification and 
  antimicrobial sensitivity testing with routine culture 
methods are difficult. Therefore, appropriate antibacterial 
therapy is generally started late. Incubation in an anaerobic 
environment may enhance the growth of this pathogen,9 
although 48–96 hours are usually required for its growth on 
nonselective routine bacteriological media. Furthermore, this 
organism is cultured most successfully on designed media, 
such as Shepard’s 10B urea broth and A8 solid medium, after 
24–48 hours of incubation.15 Media designed for   detection of 
Mycoplasma are commercially available (Remel Inc.,   Lenexa, 
KS, USA). M. hominis colonies are pinpoint sized, flat, 
measuring 20–300 µm in diameter, and have a characteristic 
fried-egg appearance when observed under 10× magnification. 
In our case, the pathogen grew under anaerobic conditions.
Mycoplasma species do not have a cell wall, which is 
the target of β-lactam antimicrobials that are commonly 
used as prophylactic agents for postsurgical   infections. 
Erythromycins are also less effective against M. hominis,10,13 
whereas M. pneumoniae is susceptible to these drugs. 
Tetracycline has historically been considered the antibiotic 
of choice for treating M. hominis infections,9,16 and 
clindamycin and lincomycin chloride are often used to treat 
  infection with tetracycline-resistant strains.9,10,17 Quinolones, 
including ciprofloxacin, ofloxacin, temafloxacin, sparfloxacin, 
trovafloxacin, gemifloxacin, gatifloxacin, moxifloxacin, 
and garenoxacin, are equally active against tetracycline-
susceptible as well as tetracycline-resistant strains of 
M. hominis.18–24 Because M. hominis is typically resistant 
to macrolides, β-lactams, aminoglycosides, vancomycin, 
trimethoprim, and sulfonamides,9,10,13,17,23,25 administration of 
effective antimicrobial agents is often initiated late.
Due to the aforementioned reasons, high fever and 
  inflammation persist for a long time in many cases of 
M. hominis infection. Polymerase chain reaction (PCR) is a 
simpler, more rapid, and more sensitive method than culturing 
for the identification of this organism; therefore, a PCR assay 
should be performed if M. hominis infection is suspected.26
In our patient, abdominal wound hematoma and abscess 
due to M. hominis were formed following cesarean   section, 
and drainage and the administration of a quinolone, cipro-
floxacin, improved the infection. To our knowledge, there 
are four published articles on the isolation of this organism 
from postcesarean incisions in which the patients developed 
hematomas.5,12–14 In one patient with M. hominis wound infec-
tion after cesarean section and in three patients with M. hominis 
and U. urealyticum infection, aspiration of the incision 
yielded a cloudy serosanguinous fluid.12,13 The serosanguinous 
exudates suggest the presence of abdominal incisional purulent 
hematoma. In a case of hematoma and abscess formation due 
to M. hominis infection at the site of a uterine incision after 
cesarean section, drainage and administration of a quinolone, 
pazufloxacin mesilate, promptly resolved the patient’s fever.14 
A perihepatic hematoma with M. hominis was observed after 
a liver transplant,27 and a perinephric hematoma was infected 
with this pathogen after a renal transplant.28 Moreover, 
hematoma infection with this bacterium developed   following 
transplant nephrectomy.29 These indicate that M. hominis 
infections after surgery may cause hematoma formation in 
immunosuppressed patients. When a hematoma with bacterial 
infection or an abscess presents, drainage,   aspiration, and 
debridement are promising treatments. Physicians may need to 
subject the specimens to bacteriological culture in an anaerobic 
environment, on designed media, or with PCR assay, to initiate 
appropriate antibacterial therapy as soon as possible if the 
causative organism is Mycoplasma.
200 µm
Small colonies on sheep blood agar culture plate
Gram stain of the colonies
40x magnification 1000x magnification
Figure 4 Mycoplasma hominis colonies grown in an anaerobic environment. They were pinpoint sized, translucent, and measuring 50–300 µm in diameter. subsequently, the 
colonies were Gram stained to be visualized more distinctly.International Journal of Women’s Health
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The route of wound infection by M. hominis in this case 
is unknown. One possible speculation is that the pathogen 
invaded and infected fetal membranes and amniotic fluid 
from the vagina or uterine cervix during pregnancy, resulting 
in postcesarean infection.
Conclusion
We present a case of abdominal wound infection by M. hominis 
following cesarean section. Based on our observation, this 
pathogen may cause hematoma   formation with or without 
abscess after cesarean section or in   immunosuppressed postop-
erative patients. In such cases, physicians may need to suspect 
Mycoplasma infection and start effective   antimicrobial treat-
ment as soon as possible in order to avoid persistent fever.
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